|
Volume 270,
Number 33,
Issue of August 18, pp. 19417-19421, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Glycoprotein
330/Low Density Lipoprotein Receptor-related Protein-2 Mediates
Endocytosis of Low Density Lipoproteins via Interaction with
Apolipoprotein B100
(Received for publication, May 10,
1995; and in revised form, June 16, 1995)
Steingrimur
Stefansson
, <WBR>
David A.
Chappell
, <WBR>
Kelley M.
Argraves
, <WBR>
Dudley K.
Strickland
, <WBR>
W.
Scott
Argraves
The ability of glycoprotein 330/low density lipoprotein
receptor-related protein-2 (LRP-2) to function as a lipoprotein
receptor was investigated using cultured mouse F9 teratocarcinoma
cells. Treatment with retinoic acid and dibutyryl cyclic AMP, which
induces F9 cells to differentiate into endoderm-like cells, produced a
50-fold increase in the expression of LRP-2. Levels of the other
members of the low density lipoprotein (LDL) receptor (LDLR) family,
including LDLR, the very low density lipoprotein receptor, and LRP-1,
were reduced. When LDL catabolism was examined in these cells, it was
found that the treated cells endocytosed and degraded at 10-fold higher
levels than untreated cells. The increased LDL uptake coincided with
increased LRP-2 activity of the treated cells, as measured by uptake of
both I-labeled monoclonal LRP-2 antibody and the LRP-2
ligand prourokinase. The ability of LDL to bind to LRP-2 was
demonstrated by solid-phase binding assays. This binding was
inhibitable by LRP-2 antibodies, receptor-associated protein (the
antagonist of ligand binding for all members of the LDLR family), or
antibodies to apoB100, the major apolipoprotein component of LDL. In
cell assays, LRP-2 antibodies blocked the elevated I-LDL
internalization and degradation observed in the retinoic acid/dibutyryl
cyclic AMP-treated F9 cells. A low level of LDL endocytosis existed
that was likely mediated by LDLR since it could not be inhibited by
LRP-2 antibodies, but was inhibited by excess LDL, receptor-associated
protein, or apoB100 antibody. The results indicate that LRP-2 can
function to mediate cellular endocytosis of LDL, leading to its
degradation. LRP-2 represents the second member of the LDLR family
identified as functioning in the catabolism of LDL.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Dugue-Pujol, X. Rousset, D. Chateau, D. Pastier, C. Klein, J. Demeurie, C. Cywiner-Golenzer, M. Chabert, P. Verroust, J. Chambaz, et al.
Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration
J. Lipid Res.,
October 1, 2007;
48(10):
2151 - 2161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Spencer and I. M. Verma
From the Cover: Targeted delivery of proteins across the blood-brain barrier
PNAS,
May 1, 2007;
104(18):
7594 - 7599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Allen, K. B. Piontek, E. Garrett-Mayer, M. Garcia-Gonzalez, K. L. Gorelick, and G. G. Germino
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors
Hum. Mol. Genet.,
January 1, 2006;
15(1):
11 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yoshida and Y. Wada
Transfer of maternal cholesterol to embryo and fetus in pregnant mice
J. Lipid Res.,
October 1, 2005;
46(10):
2168 - 2174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Verroust and E. I. Christensen
Megalin and cubilin--the story of two multipurpose receptors unfolds
Nephrol. Dial. Transplant.,
November 1, 2002;
17(11):
1867 - 1871.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. McCarthy, J. L. Barth, M. R. Chintalapudi, C. Knaak, and W. S. Argraves
Megalin Functions as an Endocytic Sonic Hedgehog Receptor
J. Biol. Chem.,
July 5, 2002;
277(28):
25660 - 25667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. McConihay, P. S. Horn, and L. A. Woollett
Effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster
J. Lipid Res.,
July 1, 2001;
42(7):
1111 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Christensen and H. Birn
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule
Am J Physiol Renal Physiol,
April 1, 2001;
280(4):
F562 - F573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Hammad, J. L. Barth, C. Knaak, and W. S. Argraves
Megalin Acts in Concert with Cubilin to Mediate Endocytosis of High Density Lipoproteins
J. Biol. Chem.,
April 14, 2000;
275(16):
12003 - 12008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. BIRN, H. VORUM, P. J. VERROUST, S. K. MOESTRUP, and E. I. CHRISTENSEN
Receptor-Associated Protein Is Important for Normal Processing of Megalin in Kidney Proximal Tubules
J. Am. Soc. Nephrol.,
February 1, 2000;
11(2):
191 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. CHRISTENSEN and T. E. WILLNOW
Essential Role of Megalin in Renal Proximal Tubule for Vitamin Homeostasis
J. Am. Soc. Nephrol.,
October 1, 1999;
10(10):
2224 - 2236.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Hammad, S. Stefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer Jr., and W. S. Argraves
Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis
PNAS,
August 31, 1999;
96(18):
10158 - 10163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. CHRISTENSEN, J. O. MOSKAUG, H. VORUM, C. JACOBSEN, T. E. GUNDERSEN, A. NYKJ&Aelig;R, R. BLOMHOFF, T. E. WILLNOW, and S. K. MOESTRUP
Evidence for an Essential Role of Megalin in Transepithelial Transport of Retinol
J. Am. Soc. Nephrol.,
April 1, 1999;
10(4):
685 - 695.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Niemeier, T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel
Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1999;
19(3):
552 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ranganathan, C. Knaak, C. R. Morales, and W. S. Argraves
Identification of Low Density Lipoprotein Receptor-related Protein-2/megalin as an Endocytic Receptor for Seminal Vesicle Secretory Protein II
J. Biol. Chem.,
February 26, 1999;
274(9):
5557 - 5563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hilpert, A. Nykjaer, C. Jacobsen, G. Wallukat, R. Nielsen, S. K. Moestrup, H. Haller, F. C. Luft, E. I. Christensen, and T. E. Willnow
Megalin Antagonizes Activation of the Parathyroid Hormone Receptor
J. Biol. Chem.,
February 26, 1999;
274(9):
5620 - 5625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. ZIAK, D. KERJASCHKI, M. G. FARQUHAR, and J. ROTH
Identification of Megalin as the Sole Rat Kidney Sialoglycoprotein Containing Poly {alpha}2,8 Deaminoneuraminic Acid
J. Am. Soc. Nephrol.,
February 1, 1999;
10(2):
203 - 209.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J Yochem, S Tuck, I Greenwald, and M Han
A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting
Development,
January 2, 1999;
126(3):
597 - 606.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rudling, M. Gafvels, P. Parini, G. Gahrton, and B. Angelin
Lipoprotein Receptors in Acute Myelogenous Leukemia : Failure to Detect Increased Low-Density Lipoprotein (LDL)Receptor Numbers in Cell Membranes despite Increased Cellular LDLDegradation
Am. J. Pathol.,
December 1, 1998;
153(6):
1923 - 1935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Cooper, J. A. Porter, K. E. Young, and P. A. Beachy
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
Science,
June 5, 1998;
280(5369):
1603 - 1607.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. L. Wyne and L. A. Woollett
Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes
J. Lipid Res.,
March 1, 1998;
39(3):
518 - 530.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Hammad, S. Ranganathan, E. Loukinova, W. O. Twal, and W. S. Argraves
Interaction of Apolipoprotein J-Amyloid beta -Peptide Complex with Low Density Lipoprotein Receptor-related Protein-2/Megalin. A MECHANISM TO PREVENT PATHOLOGICAL ACCUMULATION OF AMYLOID beta -PEPTIDE
J. Biol. Chem.,
July 25, 1997;
272(30):
18644 - 18649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Orlando, M. Exner, R.-P. Czekay, H. Yamazaki, A. Saito, R. Ullrich, D. Kerjaschki, and M. G. Farquhar
Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions
PNAS,
March 18, 1997;
94(6):
2368 - 2373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.A. Beachy, M.K. Cooper, K.E. Young, D.P. von Kessler, W.-J. Park, T.M. T. Hall, D.J. Leahy, and J.A. Porter
Multiple Roles of Cholesterol in Hedgehog Protein Biogenesis and Signaling
Cold Spring Harb Symp Quant Biol,
January 1, 1997;
62(0):
191 - 204.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Swarnakar, J. Beers, D. K. Strickland, S. Azhar, and D. L. Williams
The Apolipoprotein E-dependent Low Density Lipoprotein Cholesteryl Ester Selective Uptake Pathway in Murine Adrenocortical Cells Involves Chondroitin Sulfate Proteoglycans and an alpha 2-Macroglobulin Receptor
J. Biol. Chem.,
June 8, 2001;
276(24):
21121 - 21128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet
Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE
J. Biol. Chem.,
June 15, 2001;
276(25):
22200 - 22208.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|